ANDA vs NDA
ANDA is an abbreviated application for approving a generic version of an already approved drug, while NDA is a full application for approving a new drug that needs original safety and effectiveness evidence. This comparison clarifies the word “Abbreviated” in Abbreviated New Drug Application because ANDA does not start drug approval from zero; it depends on the approved drug that came before it.
Generic Approval Route
ANDA belongs to the generic approval route. A company uses it when the proposed medicine is not being introduced as a completely new drug but as a generic version of a product that already has regulatory approval.
New Drug Approval Route
NDA belongs to the new drug approval route. A company uses it when the medicine has not already been approved and needs original evidence to support its safety, effectiveness, quality, manufacturing, and proposed labeling.
Evidence Difference
The main difference is the type of evidence needed. ANDA focuses on proving that the proposed generic drug matches an approved reference drug, while NDA must prove that a new drug is safe and effective using original development data.
Clinical Study Difference
An NDA usually needs full clinical studies because the regulator is judging a new medicine. An ANDA usually does not repeat the complete original clinical program because the proposed generic drug is evaluated against a medicine that has already been approved.
Reference Drug Role
A reference drug is central to ANDA because the generic medicine is compared with that approved product. NDA does not depend on the same comparison structure because the company is asking approval for a new medicine, not a copy of an approved one.
Application Purpose
The purpose of ANDA is to support approval of a generic drug. The purpose of NDA is to support approval of a new drug. This difference keeps the two application types separate even though both belong to drug regulation.
Simple Comparison
ANDA uses an existing approved drug as its base, so its approval path is shorter in purpose. NDA creates the original approval record for a new drug, so it carries a broader evidence burden from the beginning.
The ANDA vs NDA difference shows why ANDA is not simply a shorter name, but a different approval route built around an already approved medicine. The main ANDA full form article introduces the term before this comparison becomes useful.